Boston Scientific
(NYSE) BSX
Boston Scientific Financials at a Glance
Market Cap
$66.29BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$20.62B
Net Income (TTM)
$3.55B
EPS (TTM)
$2.38
P/E Ratio
18.70
Dividend
$0.00
Beta (Volatility)
0.68 (Low)
Dividend
$0.00
Beta (Volatility)
0.68 (Low)
Price
$45.36
Volume
13,000,732.761
Open
$45.40
Price
$45.36
Volume
13,000,732.761
Open
$45.40
Previous Close
$45.30
Daily Range
$45.09 - $46.37
52-Week Range
$42.25 - $109.50
Estimated Earnings Date
Jul 29, 2026
Dividend
$0.00
Beta (Volatility)
0.68 (Low)
Price
$45.36
Volume
13,000,732.761
Open
$45.40
Previous Close
$45.30
Daily Range
$45.09 - $46.37
52-Week Range
$42.25 - $109.50
Estimated Earnings Date
Jul 29, 2026
BSX News
BSX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Boston Scientific
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
59,000
CEO
Michael F. Mahoney, MBA
Website
www.bostonscientific.comHeadquarters
Marlborough, MA 01752-1234, US
BSX Financials
Key Financial Metrics (TTM)
Gross Margin
70.41%
Operating Margin
20.12%
Net Income Margin
17.24%
Return on Equity
14.82%
Return on Capital
10.83%
Return on Assets
8.01%
Earnings Yield
5.35%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$66.29BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
1.49B
Volume
13.00M
Avg. Volume
20.71M
Financials (TTM)
Gross Profit
$14.52B
Operating Income
$4.15B
EBITDA
$5.66B
Operating Cash Flow
$4.34B
Capital Expenditure
-$899.00M
Free Cash Flow
$3.44B
Cash & ST Invst.
$1.52B
Total Debt
$11.03B
Boston Scientific Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$5.20B
+11.6%
Gross Profit
$3.61B
+22.5%
Gross Margin
69.44%
N/A
Market Cap
$66.29BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$1.25M
N/A
Employees
53,000
N/A
Net Income
$1.34B
+98.4%
EBITDA
$1.60B
+31.7%
Quarterly Fundamentals
Total Cash
$1.52B
+110.2%
Total Debt
$11.03B
-5.8%
Accounts Receivable
$3.03B
+12.4%
Inventory
$3.12B
+8.7%
Long Term Debt
$10.99B
+0.5%
Short Term Debt
$41.00M
-94.7%
Return on Assets
8.01%
N/A
Return on Invested Capital
10.42%
N/A
Free Cash Flow
$171.00M
-51.7%
Operating Cash Flow
$348.00M
-35.7%